Developer docs
API playgroundTry for free, no card

Search company profiles

Dakota Biotech

Full company profile

uuid000ku5x

Namestring
Dakota Biotech
Legal namestring
Dakota Biotech
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Dakota Biotech is a private biotechnology company that has developed a proprietary phospholipid bilayer vesicle encapsulation platform for delivering live, metabolically active probiotics without refrigeration. The technology wraps probiotic strains in concentric phospholipid bilayers modeled on human cell membranes, achieving >90% viability at 25°C, >80% at 40°C, and a 36-month room-temperature shelf life, with triggered release at 33°C skin temperature. The Sarasota, Florida-based company has been operating since 2014 and runs a 35,000-square-foot FDA-registered manufacturing facility holding ISO 22716 and WHO GMP certifications, equipped with four semi-automated filling lines and compounding capacity of 60–1,000 gallons. All phospholipid excipients carry FDA-GRAS designation, and the platform is protected by issued and pending patents.

The company operates an exclusively B2B model with four engagement types: contract manufacturing, white-label formulations, co-development partnerships, and technology licensing. Pricing is quote-based and tailored to project complexity, formulation requirements, and regulatory pathway. Target customers are brand owners, contract manufacturers, formulators, and researchers across six application areas: dermatology and skincare (primary), hair and scalp care, women's health, oral and gut health, medical devices, and agricultural/environmental applications. Go-to-market is direct enterprise engagement through website inquiry forms, scientific and industry positioning, and partner referrals, with a stated global geographic reach.

Clinical substantiation is generated through a core partnership with Sequential Bio, an independent research organization running studies across acne, eczema, psoriasis, rosacea, sun-exposure recovery, bacterial vaginosis, and vulvovaginal candidiasis, with completion targeted by October 2026. Reported outcomes include 100% dermatitis symptom reduction at 14 days, 50% acne symptom reduction, 25% increase in skin hydration, 25% reduction in inflammation signs, and strengthened post-procedure skin barrier. The company holds CCPA- and GDPR-aligned privacy practices, has 11–50 employees, and is privately held with no disclosed funding history, revenue figures, or institutional investors.

Short descriptiontext

Dakota Biotech is a private biotechnology company that has developed a proprietary phospholipid bilayer encapsulation platform enabling shelf-stable, live probiotic delivery without refrigeration, serving B2B brand, manufacturer, and research partners across skincare, personal care, women's health, oral, medical device, and agricultural applications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSarasota, United States
HQ citystring
Sarasota
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
probiotic encapsulation, live probiotic delivery, contract manufacturing, skincare biotechnology, technology licensing
Industry4 codes
PRIMARYHLAAAFAJ
Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery)
SECONDARYAFAJAKAL
Delivery Systems & Encapsulation (Microencapsulation, Liposomes, Emulsions, Beadlets, Spray-Dried)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYAFAJAKAE
Probiotics (Strains, Spore-Formers, Synbiotic Components)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYHLAAAKAF
Process Development & Tech Transfer Services (upstream/downstream)
NAICS code3 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Pharmaceutical Preparation Manufacturing325412
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code3 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Pharmaceutical Preparations2834
  • Services-Commercial Physical & Biological Research8731
Product category
Probiotic Biotechnology Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Contract Manufacturing
TypeProfessional Services
Description

FDA-registered manufacturing services from a 35,000-square-foot facility with ISO 22716 and WHO GMP certifications. Operates four semi-automated filling lines processing 7,500 to 25,920 units per shift, with compounding capabilities from 60 to 1,000 gallon batch sizes.

dakotabiotech.com
2White-Label Formulations
TypeOne Time License
Description

Pre-formulated probiotic product offerings available for branding and distribution by partners, leveraging Dakota's encapsulation technology and manufacturing capabilities.

dakotabiotech.com
3Co-Development Partnerships
TypeProfessional Services
Description

End-to-end formulation co-development services working alongside partner R&D teams to engineer custom probiotic products from strain selection through production-ready formulations.

dakotabiotech.com
4Technology Licensing
TypeLicensing Royalties
Description

Licensing of proprietary encapsulation technology, formulation methods, and application processes to partners seeking access to defended probiotic delivery platform.

dakotabiotech.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Dakota Biotech provides a phospholipid bilayer vesicle encapsulation platform that keeps live probiotics shelf-stable and metabolically active at room temperature for up to 36 months without refrigeration. Built on this core platform, the company sells Contract Manufacturing Services from an FDA-registered, ISO 22716 and WHO GMP-certified 35,000-square-foot facility, Co-Development and Custom Probiotic Formulation Services spanning cosmetic, OTC, prescription, and medical device categories, and White-Label Formulations ready for partner branding across skin, scalp, body, vaginal, oral, and medical device applications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 100% reduction in dermatitis symptoms after 14 days of topical live probiotic treatment (dermatologist score from 1.0 to 0)
+6 more records
Product overview1 text field

Dakota Biotech offers a unified platform centered on its proprietary phospholipid bilayer encapsulation technology for delivering shelf-stable live probiotics. The portfolio consists of the Live Probiotic Encapsulation Platform as the core technology, supplemented by Contract Manufacturing Services (FDA-registered facility with ISO 22716 and WHO GMP certifications for compounding and filling), and Co-Development/Custom Probiotic Formulation Services for custom strain selection and regulatory guidance. White-label formulations are available for partners seeking ready-to-market products. The platform serves dermatological applications initially, with expansion into gut health, oral care, agricultural biosolutions, and environmental remediation.

Product and service4 records
1Live Probiotic Encapsulation Platform
CategoryCore technology platform
Description

Proprietary phospholipid bilayer vesicle technology that encapsulates live probiotics, keeping them shelf-stable and metabolically active at room temperature for up to 36 months without refrigeration; the vesicles release viable probiotics upon skin contact through triggered fusion with skin membranes, available to brand partners for licensing.

2Contract Manufacturing Services
CategoryManufacturing services
Description

FDA-registered manufacturing services operating from a 35,000-square-foot facility with ISO 22716 and WHO GMP certifications, providing probiotic formulation, compounding (60 to 1,000 gallon batch sizes in 316L stainless steel tanks), and commercial-scale filling across four semi-automated lines processing 7,500 to 25,920 units per shift, for brand partners seeking commercial probiotic production capacity.

3Co-Development and Custom Probiotic Formulation Services
CategoryProduct development services
Description

End-to-end formulation co-development partnering with brand R&D teams to engineer custom probiotic products, including strain selection, formulation optimization, stability testing, and regulatory pathway guidance across cosmetic, OTC, prescription, and medical device categories.

4White-Label Probiotic Formulations
CategoryWhite-label product offerings
Description

Ready-to-market probiotic product formulations available for licensing or white-label partnership, covering face and skin, hair and scalp, body care, vaginal health, oral health, and medical device applications, leveraging Dakota's encapsulation technology and manufacturing capabilities.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Sequential Bio is a clinical research partner that independently conducts and validates clinical studies for Dakota Biotech's probiotic encapsulation technology. Studies include investigations for acne, eczema, psoriasis, rosacea, sun exposure recovery, bacterial vaginosis, and vulvovaginal candidiasis, all independently performed and on track for completion by October 2026.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major pharmaceutical and consumer health CDMO offering formulation, encapsulation, and fill-finish services. Compares on the contract manufacturing and softgel/encapsulation side.

2Codex Beauty Labs
TypeEmerging player
Description

Probiotic skincare brand using live-fermented and biotic ingredients. Comparable as a brand-side consumer of probiotic delivery technology rather than as a CDMO.

TypeDirect peer
Description

Leading microbial and fermentation company producing probiotic strains and bioprotective cultures for food, supplement, and personal care. Comparable as a probiotic ingredient and platform supplier for consumer brands.

TypeBroad incumbent
Description

Global CDMO with encapsulation and biologics manufacturing across pharma, nutrition, and personal care. Comparable as a regulated contract manufacturer and technology licensor operating at much greater scale.

5Lallemand Health Solutions
TypeDirect peer
Description

Probiotic manufacturer producing strain-specific formulations for human health, nutrition, and skin applications. Comparable as a probiotic ingredient supplier targeting similar indication areas including dermatology.

TypeBroad incumbent
Description

Global ingredient conglomerate with a probiotics and microbiome business serving nutrition, food, and personal care. Comparable as a large-scale probiotic ingredients and biotics platform.

TypeDirect peer
Description

Global taste and nutrition company with a Ganeden-branded probiotic ingredient business serving food, beverage, and personal care. Comparable as a probiotic strain supplier with branded ingredient offerings.

TypeDirect peer
Description

Specialist probiotic ingredient company offering proprietary strains and delivery formats to consumer health brands. Comparable in business model, target customers, and probiotic IP focus.

TypeEmerging player
Description

Live-bacteria focused skincare company applying live microbial cultures to topical products. Adjacent comparable working at the consumer brand end of the same live-probiotic skincare thesis.

10Royal DSM-Firmenich (i-Health)
TypeBroad incumbent
Description

Science-based ingredient company with biotics and nutritional lipid platforms serving personal care and nutrition customers. Comparable as a diversified ingredient supplier with microbiome-adjacent IP.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dakota Biotech

Probiotic Biotechnology Manufacturingdakotabiotech.com

Dakota Biotech is a private biotechnology company that has developed a proprietary phospholipid bilayer encapsulation platform enabling shelf-stable, live probiotic delivery without refrigeration, serving B2B brand, manufacturer, and research partners across skincare, personal care, women's health, oral, medical device, and agricultural applications.

What Dakota Biotech does

Dakota Biotech is a private biotechnology company that has developed a proprietary phospholipid bilayer vesicle encapsulation platform for delivering live, metabolically active probiotics without refrigeration. The technology wraps probiotic strains in concentric phospholipid bilayers modeled on human cell membranes, achieving >90% viability at 25°C, >80% at 40°C, and a 36-month room-temperature shelf life, with triggered release at 33°C skin temperature. The Sarasota, Florida-based company has been operating since 2014 and runs a 35,000-square-foot FDA-registered manufacturing facility holding ISO 22716 and WHO GMP certifications, equipped with four semi-automated filling lines and compounding capacity of 60–1,000 gallons. All phospholipid excipients carry FDA-GRAS designation, and the platform is protected by issued and pending patents.

The company operates an exclusively B2B model with four engagement types: contract manufacturing, white-label formulations, co-development partnerships, and technology licensing. Pricing is quote-based and tailored to project complexity, formulation requirements, and regulatory pathway. Target customers are brand owners, contract manufacturers, formulators, and researchers across six application areas: dermatology and skincare (primary), hair and scalp care, women's health, oral and gut health, medical devices, and agricultural/environmental applications. Go-to-market is direct enterprise engagement through website inquiry forms, scientific and industry positioning, and partner referrals, with a stated global geographic reach.

Clinical substantiation is generated through a core partnership with Sequential Bio, an independent research organization running studies across acne, eczema, psoriasis, rosacea, sun-exposure recovery, bacterial vaginosis, and vulvovaginal candidiasis, with completion targeted by October 2026. Reported outcomes include 100% dermatitis symptom reduction at 14 days, 50% acne symptom reduction, 25% increase in skin hydration, 25% reduction in inflammation signs, and strengthened post-procedure skin barrier. The company holds CCPA- and GDPR-aligned privacy practices, has 11–50 employees, and is privately held with no disclosed funding history, revenue figures, or institutional investors.

Dakota Biotech firmographics

Firmographics
Name
Dakota Biotech
Legal name
Dakota Biotech
Website
https://dakotabiotech.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
Dakota Biotech is a private biotechnology company that has developed a proprietary phospholipid bilayer encapsulation platform enabling shelf-stable, live probiotic delivery without refrigeration, serving B2B brand, manufacturer, and research partners across skincare, personal care, women's health, oral, medical device, and agricultural applications.
Ownership category
akta.pro rank

Dakota Biotech industry classification

Industry
Product category
Probiotic Biotechnology Manufacturing
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAAFAJ
Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery)
SECONDARYAFAJAKAL
Delivery Systems & Encapsulation (Microencapsulation, Liposomes, Emulsions, Beadlets, Spray-Dried)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYAFAJAKAE
Probiotics (Strains, Spore-Formers, Synbiotic Components)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYHLAAAKAF
Process Development & Tech Transfer Services (upstream/downstream)

Keywords

  • Probiotic encapsulation
  • Live probiotic delivery
  • Contract manufacturing
  • Skincare biotechnology
  • Technology licensing

Where Dakota Biotech is headquartered

Location

Headquarters

HQ city
Sarasota
HQ country
United States
HQ region
North America

Markets served

Dakota Biotech business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Contract Manufacturing: FDA-registered manufacturing services from a 35,000-square-foot facility with ISO 22716 and WHO GMP certifications. Operates four semi-automated filling lines processing 7,500 to 25,920 units per shift, with compounding capabilities from 60 to 1,000 gallon batch sizes.
  2. White-Label Formulations: Pre-formulated probiotic product offerings available for branding and distribution by partners, leveraging Dakota's encapsulation technology and manufacturing capabilities.
  3. Co-Development Partnerships: End-to-end formulation co-development services working alongside partner R&D teams to engineer custom probiotic products from strain selection through production-ready formulations.
  4. Technology Licensing: Licensing of proprietary encapsulation technology, formulation methods, and application processes to partners seeking access to defended probiotic delivery platform.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Dakota Biotech product offering

Product offering

Core offering

Dakota Biotech provides a phospholipid bilayer vesicle encapsulation platform that keeps live probiotics shelf-stable and metabolically active at room temperature for up to 36 months without refrigeration. Built on this core platform, the company sells Contract Manufacturing Services from an FDA-registered, ISO 22716 and WHO GMP-certified 35,000-square-foot facility, Co-Development and Custom Probiotic Formulation Services spanning cosmetic, OTC, prescription, and medical device categories, and White-Label Formulations ready for partner branding across skin, scalp, body, vaginal, oral, and medical device applications.

Product overview

Dakota Biotech offers a unified platform centered on its proprietary phospholipid bilayer encapsulation technology for delivering shelf-stable live probiotics. The portfolio consists of the Live Probiotic Encapsulation Platform as the core technology, supplemented by Contract Manufacturing Services (FDA-registered facility with ISO 22716 and WHO GMP certifications for compounding and filling), and Co-Development/Custom Probiotic Formulation Services for custom strain selection and regulatory guidance. White-label formulations are available for partners seeking ready-to-market products. The platform serves dermatological applications initially, with expansion into gut health, oral care, agricultural biosolutions, and environmental remediation.

Differentiator

Problem solved

Functional benefit

Products and services

  • Live Probiotic Encapsulation Platform Proprietary phospholipid bilayer vesicle technology that encapsulates live probiotics, keeping them shelf-stable and metabolically active at room temperature for up to 36 months without refrigeration; the vesicles release viable probiotics upon skin contact through triggered fusion with skin membranes, available to brand partners for licensing.
  • Contract Manufacturing Services FDA-registered manufacturing services operating from a 35,000-square-foot facility with ISO 22716 and WHO GMP certifications, providing probiotic formulation, compounding (60 to 1,000 gallon batch sizes in 316L stainless steel tanks), and commercial-scale filling across four semi-automated lines processing 7,500 to 25,920 units per shift, for brand partners seeking commercial probiotic production capacity.
  • Co-Development and Custom Probiotic Formulation Services End-to-end formulation co-development partnering with brand R&D teams to engineer custom probiotic products, including strain selection, formulation optimization, stability testing, and regulatory pathway guidance across cosmetic, OTC, prescription, and medical device categories.
  • White-Label Probiotic Formulations Ready-to-market probiotic product formulations available for licensing or white-label partnership, covering face and skin, hair and scalp, body care, vaginal health, oral health, and medical device applications, leveraging Dakota's encapsulation technology and manufacturing capabilities.

Quantifiable outcome

  • 100% reduction in dermatitis symptoms after 14 days of topical live probiotic treatment (dermatologist score from 1.0 to 0)
  • +6 more outcomes

Companies that use Dakota Biotech

Customer profile

Segments6 records

Ideal customer profiles3 records

Dakota Biotech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Dakota Biotech partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Sequential BiocoreStrategic or Co-development PartnerSequential Bio is a clinical research partner that independently conducts and validates clinical studies for Dakota Biotech's probiotic encapsulation technology. Studies include investigations for acne, eczema, psoriasis, rosacea, sun exposure recovery, bacterial vaginosis, and vulvovaginal candidiasis, all independently performed and on track for completion by October 2026.

Scale indicators6 records

Recent moves5 records

Expansion highlights4 records

Dakota Biotech competitors and assessment

Company assessment

Broad incumbents

  • Catalent: Major pharmaceutical and consumer health CDMO offering formulation, encapsulation, and fill-finish services. Compares on the contract manufacturing and softgel/encapsulation side.
  • Lonza Group: Global CDMO with encapsulation and biologics manufacturing across pharma, nutrition, and personal care. Comparable as a regulated contract manufacturer and technology licensor operating at much greater scale.
  • ADM (Biopolis/Protexin): Global ingredient conglomerate with a probiotics and microbiome business serving nutrition, food, and personal care. Comparable as a large-scale probiotic ingredients and biotics platform.
  • Royal DSM-Firmenich (i-Health): Science-based ingredient company with biotics and nutritional lipid platforms serving personal care and nutrition customers. Comparable as a diversified ingredient supplier with microbiome-adjacent IP.

Emerging players

  • Codex Beauty Labs: Probiotic skincare brand using live-fermented and biotic ingredients. Comparable as a brand-side consumer of probiotic delivery technology rather than as a CDMO.
  • AOBiome (Mother Dirt): Live-bacteria focused skincare company applying live microbial cultures to topical products. Adjacent comparable working at the consumer brand end of the same live-probiotic skincare thesis.

Direct peers

  • Novonesis (formerly Chr. Hansen): Leading microbial and fermentation company producing probiotic strains and bioprotective cultures for food, supplement, and personal care. Comparable as a probiotic ingredient and platform supplier for consumer brands.
  • Lallemand Health Solutions: Probiotic manufacturer producing strain-specific formulations for human health, nutrition, and skin applications. Comparable as a probiotic ingredient supplier targeting similar indication areas including dermatology.
  • Kerry Group (Ganeden): Global taste and nutrition company with a Ganeden-branded probiotic ingredient business serving food, beverage, and personal care. Comparable as a probiotic strain supplier with branded ingredient offerings.
  • Probi AB: Specialist probiotic ingredient company offering proprietary strains and delivery formats to consumer health brands. Comparable in business model, target customers, and probiotic IP focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Dakota Biotech social profiles

Digital presence

Dakota Biotech compliance and trust

Trust signal

Compliance6 records

Dakota Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dakota Biotech leadership team

Management profile

Number of profiles

Dakota Biotech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dakota Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dakota Biotech

What does Dakota Biotech do?

Dakota Biotech provides a phospholipid bilayer vesicle encapsulation platform that keeps live probiotics shelf-stable and metabolically active at room temperature for up to 36 months without refrigeration. Built on this core platform, the company sells Contract Manufacturing Services from an FDA-registered, ISO 22716 and WHO GMP-certified 35,000-square-foot facility, Co-Development and Custom Probiotic Formulation Services spanning cosmetic, OTC, prescription, and medical device categories, and White-Label Formulations ready for partner branding across skin, scalp, body, vaginal, oral, and medical device applications.

When was Dakota Biotech founded?

Dakota Biotech was founded in 2014. It employs 1 to 10 people.

Where is Dakota Biotech based?

Dakota Biotech is headquartered in Sarasota, United States, in the North America region.

How does Dakota Biotech make money?

Four revenue lines are on record. Contract Manufacturing is the primary driver. The others are white-Label Formulations, co-Development Partnerships and technology Licensing.

Who are Dakota Biotech's main competitors?

Broad incumbents on record are Catalent, Lonza Group, ADM (Biopolis/Protexin) and Royal DSM-Firmenich (i-Health). Emerging players are Codex Beauty Labs and AOBiome (Mother Dirt). Direct peers are Novonesis (formerly Chr. Hansen), Lallemand Health Solutions, Kerry Group (Ganeden) and Probi AB.

Does Dakota Biotech have an API?

No public API is recorded for Dakota Biotech.

What industry is Dakota Biotech in?

Dakota Biotech's product category is Probiotic Biotechnology Manufacturing. Its primary akta.pro industry code is HLAAAFAJ, Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery), with a secondary code of AFAJAKAL, Delivery Systems & Encapsulation (Microencapsulation, Liposomes, Emulsions, Beadlets, Spray-Dried). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals